Street Smart

Chinese walls and unbundled research: what MiFID changed about the notes you read

Chinese walls and MiFID research rules affect how broker notes are produced and read. Here is what private investors should actually check.

By James Beddington · June 16, 2026

A research note can look calm, objective and neatly argued. That does not mean it arrives free of incentives. If you read broker research on a small-cap share, you need to understand both the wall that is supposed to separate interests and the payment system that changed how research gets funded.

Reviewed by James Whitfield, Senior Editor · June 16, 2026, 11:37 pm BST

In this article

The Short Version

Chinese walls are internal controls meant to separate analysts from dealmaking and sales pressures.
MiFID II pushed the market toward paying for research more explicitly instead of hiding the cost inside trading commissions.
That changed incentives, but it did not eliminate conflicts, optimism or commercial pressure.
Retail investors should read research as informed analysis, not as neutral truth or a trading instruction.

What People Mean By Chinese Walls

In market slang, Chinese walls are the internal barriers meant to stop one part of a financial firm passing sensitive information to another part that could misuse it. The classic concern is simple: an analyst should not be quietly fed deal information from the investment-banking side, then publish research that flatters a client or nudges the market before the public has the full picture.

The phrase sounds old-fashioned because it is. The idea behind it is still current. Research, corporate finance, sales and trading can all sit inside the same broad organisation, but they are not supposed to behave as one combined persuasion machine. A functioning wall means limits on conversations, approvals, information access and timing. It also means records, compliance oversight and an expectation that analysts defend their work on evidence rather than on who a firm wants to please.

What MiFID Changed About Research Payments

Before MiFID II, the cost of investment research was often bundled into trading relationships. A fund manager might deal through a broker and receive research as part of the wider service package. In plain English, the cost was there, but it was less visible. MiFID II pushed the industry toward a more explicit model where research had to be priced and justified more clearly.

That mattered because pricing changes behaviour. Once research has to stand on its own feet, investors can ask harder questions: what is this note actually worth, how often is it useful, and does it improve decisions or just fill inboxes? It also matters because smaller-company coverage became a live concern. If research budgets tighten, smaller stocks can receive less attention, which changes how information reaches the market.

Why The Conflict Did Not Disappear

Unbundling research from execution did not magically produce pure objectivity. Analysts still work inside commercial firms. Brokers still care about access, relationships, corporate clients and trading flow. A wall can reduce obvious contamination, but it cannot remove softer pressures such as career incentives, tone, house view or the natural reluctance to publish a brutal note about a business your firm wants to stay close to.

That is why private investors should stop looking for a single yes or no answer to the question, “Can I trust this note?” The better question is, “What job is this note doing?” Some notes genuinely explain a business well. Some are useful for framing sector issues. Some are little more than polished marketing with financial vocabulary. The discipline is not to reject all research, but to read it with the right level of suspicion.

A Worked Example

Imagine a small-cap company has just completed a placing. A broker connected to the deal publishes a fresh note a few days later. The analyst may have done real modelling and spoken to management. The note may contain useful detail about forecasts, dilution, cash runway and the business plan. None of that means you should read it as detached from the wider commercial setting.

Ask a few plain questions. Was the firm involved in raising money? Does the note clearly separate facts from assumptions? Is the language careful about risks, or does it lean on broad optimism about a turnaround, pipeline or addressable market? Are the downside cases treated seriously, or are they brushed aside as temporary noise? A good note can survive those questions. A weak one usually starts to sound thinner once you ask them.

Why This Matters More In Small-Caps

In large, heavily covered companies, you can often compare multiple analyst views, independent reporting, broad market commentary and deeper published data. In smaller shares, the information environment is thinner. A single broker note can carry more weight simply because there is less else around it. That is exactly when the reader needs better habits.

The risk is not only that a note is too optimistic. It is that the reader mistakes access for certainty. Management access, industry familiarity and tidy models can make a document feel authoritative. But a forecast is still a forecast. A target price is still an opinion. A confident tone is still only a tone. If you have already seen how quickly narrative can move a share, our guide to what analysts actually do before a recommendation lands is a useful companion read.

How To Read A Research Note More Calmly

Start with the evidence sections before the conclusion. Look for cash, margins, debt, dilution, customer concentration, contract quality and what has actually happened since the last update. Then ask what the analyst must believe for the bull case to work. If those assumptions are demanding, write them down in plain English rather than letting the note’s tone carry you along.

It also helps to compare the note with other signals. Has the company issued an RNS that supports the same claims? Does the balance-sheet story match the optimism? Is the market reacting to facts, or to atmosphere? That is the same discipline behind our Street Smart piece on results-day theatre: separate presentation from proof.

What Unbundling Really Changed For Retail Readers

The biggest change for a retail reader is not that research became saintly or useless. It is that the market became more honest about research as a product with a cost. Once you see it that way, the tone of the note makes more sense. You are reading a paid-for research output created inside a structured commercial environment, not a neutral educational leaflet.

That is not a reason to dismiss it. It is a reason to use it correctly. Research can help you frame questions, spot risks, understand sector language and challenge your own assumptions. It becomes dangerous when you outsource judgement to it.

What This Means For You

If you are a private investor, treat broker research as one input, not the final word. Read the disclosures, check what the company itself has said, and pay attention to what is missing as much as to what is included. If a note sounds persuasive but you cannot explain the downside in your own words afterwards, you probably have not finished the reading job.

It is also worth remembering that a polished note can still arrive late to the price move. By the time a retail reader sees it, the professional conversation around the stock may already have moved on. That is why our piece on the tipster effect belongs in the same toolkit. The market story often starts before the public-facing explanation reaches you.

In Plain English

Chinese walls are supposed to stop analysts and dealmakers pulling in the same direction for the wrong reasons. MiFID changed how research gets paid for, which made some incentives clearer. Neither change means you can stop thinking for yourself.

Read the note, use the facts, question the tone and keep your own judgement in charge.